Literature DB >> 22575762

A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells.

Stephanie Protze1, Shahryar Khattak, Claire Poulet, Dirk Lindemann, Elly M Tanaka, Ursula Ravens.   

Abstract

The simultaneous overexpression of several transcription factors has emerged as a successful strategy to convert fibroblasts into other cell types including pluripotent cells, neurons, and cardiomyocytes. The selection and screening of factors are critical, and have often involved testing a large pool of transcription factors, followed by successive removal of single factors. Here, to identify a cardiac transcription factor combination facilitating mouse fibroblast reprogramming into cardiomyocytes, we directly screened all triplet combinations of 10 candidate factors combined with a Q-PCR assay reporting induction of multiple cardiac-specific genes. Through this screening method the combination of Tbx5, Mef2c, and Myocd was identified to upregulate a broader spectrum of cardiac genes compared to the combination of Tbx5, Mef2c, and Gata4 that was recently shown to induce reprogramming of fibroblasts into cardiomyocytes. Cells cotransduced with Tbx5, Mef2c, Myocd expressed cardiac contractile proteins, had cardiac-like potassium and sodium currents and action potentials could be elicited. In summary the alternative screening approach that is presented here avoided the elimination of transcription factors whose potency is masked in complex transcription factor mixes. Furthermore, our results point to the importance of verifying multiple lineage specific genes when assessing reprogramming.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22575762     DOI: 10.1016/j.yjmcc.2012.04.010

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  100 in total

1.  In vivo reprogramming for heart disease.

Authors:  Huansheng Xu; B Alexander Yi; Kenneth R Chien
Journal:  Cell Res       Date:  2012-07-03       Impact factor: 25.617

2.  Critical factors for cardiac reprogramming.

Authors:  Deepak Srivastava; Masaki Ieda
Journal:  Circ Res       Date:  2012-06-22       Impact factor: 17.367

3.  In vivo cardiac reprogramming using an optimal single polycistronic construct.

Authors:  Hong Ma; Li Wang; Chaoying Yin; Jiandong Liu; Li Qian
Journal:  Cardiovasc Res       Date:  2015-09-23       Impact factor: 10.787

Review 4.  Cardiac reprogramming: from mouse toward man.

Authors:  Deepak Srivastava; Emily C Berry
Journal:  Curr Opin Genet Dev       Date:  2013-08-28       Impact factor: 5.578

Review 5.  The non-coding road towards cardiac regeneration.

Authors:  James E Hudson; Enzo R Porrello
Journal:  J Cardiovasc Transl Res       Date:  2013-12       Impact factor: 4.132

6.  Reprogramming of mouse fibroblasts into cardiomyocyte-like cells in vitro.

Authors:  Li Qian; Emily C Berry; Ji-dong Fu; Masaki Ieda; Deepak Srivastava
Journal:  Nat Protoc       Date:  2013-05-30       Impact factor: 13.491

Review 7.  Direct cardiomyocyte reprogramming: a new direction for cardiovascular regenerative medicine.

Authors:  B Alexander Yi; Christine L Mummery; Kenneth R Chien
Journal:  Cold Spring Harb Perspect Med       Date:  2013-09-01       Impact factor: 6.915

Review 8.  Molecular discoveries and treatment strategies by direct reprogramming in cardiac regeneration.

Authors:  John H Werner; John H Rosenberg; John Y Um; Michael J Moulton; Devendra K Agrawal
Journal:  Transl Res       Date:  2018-07-31       Impact factor: 7.012

9.  Re-patterning of H3K27me3, H3K4me3 and DNA methylation during fibroblast conversion into induced cardiomyocytes.

Authors:  Ziqing Liu; Olivia Chen; Michael Zheng; Li Wang; Yang Zhou; Chaoying Yin; Jiandong Liu; Li Qian
Journal:  Stem Cell Res       Date:  2016-02-27       Impact factor: 2.020

10.  Generation of an inducible fibroblast cell line for studying direct cardiac reprogramming.

Authors:  Haley Ruth Vaseghi; Chaoying Yin; Yang Zhou; Li Wang; Jiandong Liu; Li Qian
Journal:  Genesis       Date:  2016-06-01       Impact factor: 2.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.